The most successful way and major goal for treating Alzheimer's disease is to diminish acetylcholine levels by using transitory inhibitors to block the cholinesterase that AChE and BuChE catalyze (Sang et al., 2022). The gene discussed is ACHE; the disease is Alzheimer disease.